Matthew James
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin (NCT06886464) | Matthew James | 2025-07-16 |
Track Matthew James automatically
Every clearance here is in the API, with alerts when new ones post.